Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Antifungal Drug Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Echinocandins
  • 1.3.3 Azoles
  • 1.3.4 Ployenes
  • 1.3.5 Allylamines
• 1.4 Market Segment by Application
  • 1.4.1 Global Antifungal Drug Market Share by Application (2019-2025)
  • 1.4.2 Aspergillosis
  • 1.4.3 Dermatophytosis
  • 1.4.4 Candidiasis
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Antifungal Drug Market Size
  • 2.1.1 Global Antifungal Drug Revenue 2014-2025
  • 2.1.2 Global Antifungal Drug Sales 2014-2025
• 2.2 Antifungal Drug Growth Rate by Regions
  • 2.2.1 Global Antifungal Drug Sales by Regions 2014-2019
  • 2.2.2 Global Antifungal Drug Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Antifungal Drug Sales by Manufacturers
  • 3.1.1 Antifungal Drug Sales by Manufacturers 2014-2019
  • 3.1.2 Antifungal Drug Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Antifungal Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antifungal Drug Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Antifungal Drug Market Concentration Ratio (CR5 and HHI)
• 3.3 Antifungal Drug Price by Manufacturers
• 3.4 Key Manufacturers Antifungal Drug Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Antifungal Drug Market
• 3.6 Key Manufacturers Antifungal Drug Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Echinocandins Sales and Revenue (2014-2019)
  • 4.1.2 Azoles Sales and Revenue (2014-2019)
  • 4.1.3 Ployenes Sales and Revenue (2014-2019)
  • 4.1.4 Allylamines Sales and Revenue (2014-2019)
• 4.2 Global Antifungal Drug Sales Market Share by Type
• 4.3 Global Antifungal Drug Revenue Market Share by Type
• 4.4 Antifungal Drug Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Antifungal Drug Sales by Application

6 United States

• 6.1 United States Antifungal Drug Breakdown Data by Company
• 6.2 United States Antifungal Drug Breakdown Data by Type
• 6.3 United States Antifungal Drug Breakdown Data by Application

7 European Union

• 7.1 European Union Antifungal Drug Breakdown Data by Company
• 7.2 European Union Antifungal Drug Breakdown Data by Type
• 7.3 European Union Antifungal Drug Breakdown Data by Application

8 China

• 8.1 China Antifungal Drug Breakdown Data by Company
• 8.2 China Antifungal Drug Breakdown Data by Type
• 8.3 China Antifungal Drug Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Antifungal Drug Breakdown Data by Company
• 9.2 Rest of World Antifungal Drug Breakdown Data by Type
• 9.3 Rest of World Antifungal Drug Breakdown Data by Application
• 9.4 Rest of World Antifungal Drug Breakdown Data by Countries
  • 9.4.1 Rest of World Antifungal Drug Sales by Countries
  • 9.4.2 Rest of World Antifungal Drug Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Asperqillus
  • 10.1.1 Asperqillus Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.1.4 Antifungal Drug Product Introduction
  • 10.1.5 Asperqillus Recent Development
• 10.2 Alternaria
  • 10.2.1 Alternaria Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.2.4 Antifungal Drug Product Introduction
  • 10.2.5 Alternaria Recent Development
• 10.3 Abbott Laboratories
  • 10.3.1 Abbott Laboratories Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.3.4 Antifungal Drug Product Introduction
  • 10.3.5 Abbott Laboratories Recent Development
• 10.4 Pfizer
  • 10.4.1 Pfizer Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.4.4 Antifungal Drug Product Introduction
  • 10.4.5 Pfizer Recent Development
• 10.5 Glaxosmithkline
  • 10.5.1 Glaxosmithkline Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.5.4 Antifungal Drug Product Introduction
  • 10.5.5 Glaxosmithkline Recent Development
• 10.6 Bayer Healthcare
  • 10.6.1 Bayer Healthcare Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.6.4 Antifungal Drug Product Introduction
  • 10.6.5 Bayer Healthcare Recent Development
• 10.7 Novartis
  • 10.7.1 Novartis Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.7.4 Antifungal Drug Product Introduction
  • 10.7.5 Novartis Recent Development
• 10.8 Sanofi-Aventis
  • 10.8.1 Sanofi-Aventis Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.8.4 Antifungal Drug Product Introduction
  • 10.8.5 Sanofi-Aventis Recent Development
• 10.9 Merck & Co.
  • 10.9.1 Merck & Co. Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.9.4 Antifungal Drug Product Introduction
  • 10.9.5 Merck & Co. Recent Development
• 10.10 Kramer Laboratories
  • 10.10.1 Kramer Laboratories Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Antifungal Drug
  • 10.10.4 Antifungal Drug Product Introduction
  • 10.10.5 Kramer Laboratories Recent Development
• 10.11 Enzon Pharmaceuticals
• 10.12 Gilead

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Antifungal Drug Sales Channels
  • 11.2.2 Antifungal Drug Distributors
• 11.3 Antifungal Drug Customers

12 Market Forecast

• 12.1 Global Antifungal Drug Sales and Revenue Forecast 2019-2025
• 12.2 Global Antifungal Drug Sales Forecast by Type
• 12.3 Global Antifungal Drug Sales Forecast by Application
• 12.4 Antifungal Drug Forecast by Regions
  • 12.4.1 Global Antifungal Drug Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Antifungal Drug Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

An antifungal medication, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others.
In 2019, the market size of Antifungal Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antifungal Drug.

This report studies the global market size of Antifungal Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antifungal Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Asperqillus
Alternaria
Abbott Laboratories
Pfizer
Glaxosmithkline
Bayer Healthcare
Novartis
Sanofi-Aventis
Merck & Co.
Kramer Laboratories
Enzon Pharmaceuticals
Gilead

Market Segment by Product Type
Echinocandins
Azoles
Ployenes
Allylamines

Market Segment by Application
Aspergillosis                                                           
Dermatophytosis                                                 
Candidiasis

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Antifungal Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antifungal Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antifungal Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025